Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Published:2020-07-30 Issue:1 Volume:35 Page:225-228
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Del Galy A. Sutra^ORCID,Marouf A.,Raffoux E.,Robin M.,Michonneau D.^ORCID,Sébert M.,Sicre de Fontebrune F.,Xhaard A.^ORCID,Lengline E.,Itzykson R.^ORCID,Frieri C.,Dombret H.,Fenaux P.,Peffault de Latour R.,Adès L.^ORCID,Socié G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-1004-9.pdf

Reference15 articles.

1. Malcovati L, Hellström-Lindberg E, Bowen D, Adès L, Cermak J, del Cañizo C, et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood. 2013;122:2943–64.

2. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.

3. Lancet JE, Uy GL, Cortes JE, Newell LF, Lin TL, Ritchie EK, et al. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. JCO. 2018;36:2684–92.

4. DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, et al. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019;133:7–17.

5. Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, et al. Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States. Blood. 2017;130:1156–64.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores;American Journal of Hematology;2023-04-05

2. Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience;Haematologica;2023-03-23

3. Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation;Bone Marrow Transplantation;2022-06-02

4. A randomised phase II study of azacitidine ( AZA ) alone or with Lenalidomide ( LEN ), Valproic acid ( VPA ) or Idarubicin ( IDA ) in higher‐Risk MDS or low blast AML : GFM 's “pick a winner” trial, with the impact of somatic mutations;British Journal of Haematology;2022-04-19

5. Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review;Stem Cell Research & Therapy;2022-03-04